TD Asset Management »

Avalo Therapeutics Ord shares owned by TD Asset Management

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by TD Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $768k 51k 14.93

More positions owned by TD Asset Management

NVIDIA Corporation (NVDA)
Rbc Cad (RY)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Microsoft Corporation (MSFT)
Bank Of Montreal Cadcom (BMO)
Alphabet Cap Stk Cl A (GOOGL)
Enbridge (ENB)
Cibc Cad (CM)
Broadcom (AVGO)
Agnico (AEM)
Canadian Natural Resources (CNQ)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Suncor Energy (SU)
Amazon (AMZN)

View all positions for TD Asset Management

Top funds holding Avalo Therapeutics Ord

BVF
Logos Global Management
Nantahala Capital Management
UBS Group
Affinity Asset Advisors
Point72 Asset Management
Caligan Partners
Millennium Management
Vanguard Group
TCG Crossover Management
Balyasny Asset Management
Vanguard Capital Management
RA Capital Management
Bank of America Corporation
Ikarian Capital

View all funds holding Avalo Therapeutics Ord